Ethical and academic dilemmas in authorship of clinical research publications: a medical oncologist's perspective.

IF 3.5 4区 医学 Q2 ONCOLOGY Medical Oncology Pub Date : 2025-02-11 DOI:10.1007/s12032-025-02617-4
Ozgur Tanriverdi
{"title":"Ethical and academic dilemmas in authorship of clinical research publications: a medical oncologist's perspective.","authors":"Ozgur Tanriverdi","doi":"10.1007/s12032-025-02617-4","DOIUrl":null,"url":null,"abstract":"<p><p>Authorship in clinical research carries significant academic, financial, and social implications. However, determining rightful authorship often introduces ethical and professional dilemmas, particularly in large, multidisciplinary studies, such as those common in oncology. This article explores the ethical complexities surrounding authorship in clinical research from the viewpoint of a medical oncologist. It addresses issues, such as academic jealousy, the inclusion of industry-affiliated researchers, honorary authorship, and the role of patient recruitment in authorship qualification. By examining current guidelines, ethical considerations, and practical cases, this paper aims to offer insights into fostering fair and transparent authorship practices in the field of clinical oncology.</p>","PeriodicalId":18433,"journal":{"name":"Medical Oncology","volume":"42 3","pages":"74"},"PeriodicalIF":3.5000,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11813949/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12032-025-02617-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Authorship in clinical research carries significant academic, financial, and social implications. However, determining rightful authorship often introduces ethical and professional dilemmas, particularly in large, multidisciplinary studies, such as those common in oncology. This article explores the ethical complexities surrounding authorship in clinical research from the viewpoint of a medical oncologist. It addresses issues, such as academic jealousy, the inclusion of industry-affiliated researchers, honorary authorship, and the role of patient recruitment in authorship qualification. By examining current guidelines, ethical considerations, and practical cases, this paper aims to offer insights into fostering fair and transparent authorship practices in the field of clinical oncology.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
临床研究出版物作者身份的伦理和学术困境:医学肿瘤学家的观点。
临床研究的作者身份具有重要的学术、经济和社会意义。然而,确定合法的作者身份往往会带来伦理和专业上的困境,特别是在大型、多学科的研究中,如肿瘤学中常见的研究。本文从医学肿瘤学家的角度探讨了临床研究中作者身份的伦理复杂性。它解决了一些问题,如学术嫉妒、行业附属研究人员的纳入、荣誉作者以及作者资格中患者招募的作用。通过研究当前的指导方针、伦理考虑和实际案例,本文旨在为促进临床肿瘤学领域公平透明的作者身份实践提供见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Medical Oncology
Medical Oncology 医学-肿瘤学
CiteScore
4.20
自引率
2.90%
发文量
259
审稿时长
1.4 months
期刊介绍: Medical Oncology (MO) communicates the results of clinical and experimental research in oncology and hematology, particularly experimental therapeutics within the fields of immunotherapy and chemotherapy. It also provides state-of-the-art reviews on clinical and experimental therapies. Topics covered include immunobiology, pathogenesis, and treatment of malignant tumors.
期刊最新文献
Disrupting the USP1-UAF1 deubiquitinase complex: a master regulator of replication stress and frontier target in cancer therapy. Patient-derived spheroid culture: A promising in vitro model for drug screening in retinoblastoma. A natural nephroprotective adjuvant for cancer chemotherapy: Rosmarinic acid disrupts IL-17 A-Ferroptosis coupling in Ifosfamide-induced renal injury. Research progress and clinical translation challenges in the use of oncolytic bacteria for cancer therapy. Retraction Note: The physician payments sunshine act and medical oncology: a seven-year financial analysis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1